Isotretinoin Therapy and Physical Activity - Implications for Athletes and Physically Active Individuals
DOI:
https://doi.org/10.12775/QS.2026.56.72382Keywords
isotretinoin, acne vulgaris, physical activity, athletes, adverse effectsAbstract
Background. Isotretinoin is widely used and highly effective in the treatment of severe acne. However, its use is associated with a broad range of adverse effects, some of which may be particularly relevant in physically active individuals. Athletes are often exposed to factors that increase the risk of acne and may therefore be more likely to require systemic treatment. At the same time, the potential impact of isotretinoin on physical performance and training remains unclear.
Aim. The aim of this narrative review was to summarise the current knowledge on the adverse effects of isotretinoin, with a focus on those that may be important in physically active individuals.
Material and methods. A literature search was performed using PubMed
and Web of Science databases, including studies published between 2016 and 2026. The search included terms related to isotretinoin, physical activity, exercise, and adverse effects. Only articles published in English were considered, and the results were reviewed and organised thematically.
Results. The findings suggest that isotretinoin may affect several organ systems. Musculoskeletal symptoms, such as muscle and joint pain or increased creatine kinase levels, seem particularly relevant in individuals who engage in regular physical activity. Ocular and mucocutaneous side effects, although usually mild, may still influence comfort during exercise. The relationship between isotretinoin and mental health appears more complex, with most studies indicating a low overall risk, but some patients still reporting mood-related symptoms.
Conclusions. While isotretinoin is an effective treatment, its effects are not limited to the skin and may be more noticeable in physically active individuals. In this group, even mild side effects can affect training and overall well-being. At the same time, there is still a lack of research focused specifically on athletes, which highlights the need for further studies in this area.
References
1. Pujalte GGA, Costa LMC, Clapp AD, Presutti RJ, Sluzevich JC. More Than Skin Deep: Dermatologic Conditions in Athletes. Sports Health. 2023 Jan 1;15(1):74–85. doi:10.1177/19417381211065026 PubMed PMID: 35034516.
2. Muhaidat J, Qablan A, Gharaibeh F, Albataineh GH, Abdo N, Alshiyab D, et al. The Effect of Whey Protein Supplements on Acne Vulgaris among Male Adolescents and Young Adults: A Case-Control Study from North of Jordan. Dermatol Res Pract. 2024;2024. doi:10.1155/2024/2158229
3. Pile HD, Patel P. Isotretinoin. Handbook of Systemic Drug Treatment in Dermatology: Second Edition [Internet]. StatPearls Publishing; 2025 [cited 2026 Apr 13]. 184–193 p. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525949/ doi:10.1201/b18491-23 PubMed PMID: 30247824.
4. Raneses E, Schmidgal EC. Rhabdomyolysis Caused by Isotretinoin and Exercise in an Otherwise Healthy Female Patient. Cureus. 2022 Jun 16. doi:10.7759/cureus.25981
5. U.S. Food and Drug Administration. Absorica (isotretinoin) drug label [Internet]. 2018 Aug [cited 2026 Apr 8]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021951s014lbl.pdf
6. Paichitrojjana A, Paichitrojjana A. Oral Isotretinoin and Its Uses in Dermatology: A Review. Drug Design, Development and Therapy. Dove Medical Press Ltd; 2023. p. 2573–91. doi:10.2147/DDDT.S427530 PubMed PMID: 37649956.
7. Alison Layton. The use of isotretinoin in acne. Dermatoendocrinol. 2009 May;(1:3):162–9. doi:10.4161/derm.1.3.9364
8. Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. Journal of Investigative Dermatology. 2006 Oct 30;126(10):2178–89. doi:10.1038/sj.jid.5700289 PubMed PMID: 16575387.
9. Tsukada M, Schröder M, Roos TC, Chandraratna RAS, Reichert U, Merk HF, et al. 13-Cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans Retinoic acid and binding to retinoid acid receptors. Journal of Investigative Dermatology. 2000;115(2):321–7. doi:10.1046/j.1523-1747.2000.00066.x PubMed PMID: 10951254.
10. Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, Nelson AM, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. Journal of Investigative Dermatology. 2012;132(9):2198–205. doi:10.1038/jid.2012.111
11. Demirbas A, Demirbas GU, Diremsizoglu E, Islamoglu G. Systemic Anti-Inflammatory Effects of Isotretinoin: Evaluation of Red Cell Distribution Width to Lymphocyte and Platelet Ratios as New Hematological Markers and Clinical Outcomes in Acne Vulgaris. J Cosmet Dermatol. 2025 Mar 1;24(3). doi:10.1111/jocd.70108 PubMed PMID: 40062686.
12. Almutairi RR, Almutairi AG, Alhallafi AF, Almudawi NA, AlSulaiman MA, Shadid AM, et al. Isotretinoin musculoskeletal side effects: a systematic review. Dermatol Reports. 2024;16(4). doi:10.4081/dr.2024.9845
13. Drozd M, Czarnota J, Dobrzyński M, Skubel T, Sokół D, Dudek I, et al. Impact of oral isotretinoin therapy on musculoskeletal system and physical activity in patients with acne. Journal of Education, Health and Sport. 2020 Aug 26;10(8):372–82. doi:10.12775/JEHS.2020.10.08.045
14. Karaosmanoǧlu N, Mülkoǧlu C. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: A cross-sectional study. BMC Musculoskelet Disord. 2020 Sep 25;21(1). doi:10.1186/s12891-020-03656-w PubMed PMID: 32977793.
15. Acar EM, Şaş S, Koçak FA. Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study. Arch Rheumatol. 2022 Jun 1;37(2):223–9. doi:10.46497/ArchRheumatol.2022.8645
16. Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017 Feb 1;97(2):173–81. doi:10.2340/00015555-2535 PubMed PMID: 27671426.
17. Marson JW, Baldwin HE, Brooklyn B, York N, Brunswick N, Jersey N. Elevated creatine kinase levels, exercise, and isotretinoin for acne. JAAD Case Rep. 2022 Mar 1;21:133. doi:10.1016/J.JDCR.2021.07.044 PubMed PMID: 35242965.
18. Baykal Selçuk L, Aksu Arıca D, Baykal Şahin H, Yaylı S, Bahadır S. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin. Cutan Ocul Toxicol. 2017 Apr 3;36(2):176–9. doi:10.1080/15569527.2016.1237521 PubMed PMID: 27764978.
19. Feily A. Successful treatment of isotretinoin induced musculoskeletal pain by vitamin B12 and folic acid. Open Access Macedonian Journal of Medical Sciences. Open Access Macedonian Journal of Medical Sciences; 2019. p. 3726–7. doi:10.3889/oamjms.2019.799
20. Dasgupta K, Lim P, Reedstorm H. A Common Drug With a Dangerous Side Effect: Acute Rhabdomyolysis Caused by the Synergistic Effect of Isotretinoin and Exercise in an Adolescent. Cureus. 2020 Oct 13. doi:10.7759/CUREUS.10929
21. Aidek S, Ibrahim K, Alaqqad M, Gumaa A, AbouHelwo A. When Medications Harm Muscles: A Case of a Teenager With Acute Rhabdomyolysis. Cureus. 2026 Jan 9. doi:10.7759/cureus.101173
22. Mahyar M, Jahanbazi R, Khorram A, Shahramirad S, Vataniman M. Isotretinoin‐Associated Myopathy With Normal Creatine Kinase ( CK ) Levels: EMG ‐Based Diagnosis at Low Dose—A Case Report . Clin Case Rep. 2025 Oct;13(10). doi:10.1002/ccr3.71210
23. Mülkoğlu C, Karaosmanoğlu N. Effect of oral isotretinoin on muscle strength in patients with acne vulgaris: a prospective controlled study. BMC Pharmacol Toxicol. 2021 Dec 1;22(1). doi:10.1186/s40360-021-00483-0 PubMed PMID: 33743831.
24. Kapała J, Lewandowska J, Placek W, Owczarczyk-Saczonek A. Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis. International Journal of Environmental Research and Public Health. MDPI; 2022. doi:10.3390/ijerph19116463 PubMed PMID: 35682048.
25. Feszak IJ, Brzeziński P, Feszak S, Kitowska A, Waśkow M, Kawczak P, et al. Isotretinoin Treatment for Acne Vulgaris: A Five-Year Retrospective Analysis of Clinical and Biochemical Adverse Effects. J Clin Med. 2025 Sep 1;14(18). doi:10.3390/jcm14186473
26. Moy A, McNamara NA, Lin MC. Effects of Isotretinoin on Meibomian Glands. Optom Vis Sci. 2015 Sep 5;92(9):925–30. doi:10.1097/OPX.0000000000000656 PubMed PMID: 26154692.
27. Zhang P, Tian L, Bao J, Li S, Li A, Wen Y, et al. Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway. Invest Ophthalmol Vis Sci. 2022 Mar 1;63(3). doi:10.1167/iovs.63.3.29 PubMed PMID: 35353124.
28. De Queiroga IBW, Antônio Vieira L, Barros JDN, Melo Diniz MDFF, De Morais LCSL. Conjunctival impression cytology changes induced by oral isotretinoin. Cornea. 2009;28(9):1009–13. doi:10.1097/ICO.0B013E3181A16858 PubMed PMID: 19724211.
29. Aslan Bayhan S, Bayhan HA, Çölgeçen E, Gürdal C. Effects of topical acne treatment on the ocular surface in patients with acne vulgaris. Contact Lens and Anterior Eye. 2016 Dec 1;39(6):431–4. doi:10.1016/j.clae.2016.06.009 PubMed PMID: 27422575.
30. Abuallut II, Dibaji MQ, Assiri A, Mawkili W, Najmi AY, Ageeli SA, et al. Oral Isotretinoin-Associated Ocular Effects and Risk Factors: A Cross-Sectional Study. Clinical Ophthalmology. 2024;18:4041–52. doi:10.2147/OPTH.S491757
31. Fouladgar N, Khabazkhoob M, Hanifnia AR, Yekta A, Mirzajani A. Evaluation of the effects of isotretinoin for treatment of acne on corneal sensitivity. J Curr Ophthalmol. 2018 Dec 1;30(4):326–9. doi:10.1016/J.JOCO.2018.06.005 PubMed PMID: 30555965.
32. Barros A, Lozano-Sanroma J, Queiruga-Piñeiro J, Fernández-Vega-Cueto L, Sánchez-Fernández C, Merayo-Lloves J, et al. In vivo confocal microscopy provides evidence of corneal nerve damage and basal tear film reduction in patients treated with oral isotretinoin. J Transl Med. 2025 Dec 1;23(1). doi:10.1186/s12967-025-06577-1 PubMed PMID: 40380252.
33. Wu SN, Huang C, Wang YQ, Chen XD, Li X, Zhang SQ, et al. Real-World Large Sample Assessment of Drug-related Dry Eye Risk: Based on the FDA Adverse Event Reporting System Database. Asia-Pacific Journal of Ophthalmology. 2024 Sep 1;13(5). doi:10.1016/j.apjo.2024.100104 PubMed PMID: 39343068.
34. U.S. Food and Drug Administration. Absorica (isotretinoin) drug label [Internet]. 2018 Aug [cited 2026 Apr 8]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021951s014lbl.pdf
35. Tan NKW, Tang A, MacAlevey NCYL, Tan BKJ, Oon HH. Risk of Suicide and Psychiatric Disorders among Isotretinoin Users: A Meta-Analysis. JAMA Dermatol. 2024 Jan 17;160(1):54–62. doi:10.1001/jamadermatol.2023.4579 PubMed PMID: 38019562.
36. Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data*. British Journal of Dermatology. 2022 Jul 1;187(1):64–72. doi:10.1111/bjd.21049 PubMed PMID: 35174880.
37. Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr Dermatol. 2024 Jul 1;41(4):635–40. doi:10.1111/pde.15595 PubMed PMID: 38500340.
38. Szilagyi DV, Tit DM, Judea-Pusta CT, Radu AF, Bungau GS, Radu A, et al. Real-World Evidence of Neuropsychiatric Adverse Reactions to Isotretinoin: Insights from EudraVigilance (2005–2025). Pharmaceuticals. 2025 Sep 1;18(9). doi:10.3390/ph18091252
39. Lee YH, Scharnitz TP, Muscat J, Chen A, Gupta-Elera G, Kirby JS. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis. JAMA Dermatol. 2016 Jan 1;152(1):35–44. doi:10.1001/JAMADERMATOL.2015.3091 PubMed PMID: 26630323.
40. Mirnezami M, Rahimi H. Is Oral Omega-3 Effective in Reducing Mucocutaneous Side Effects of Isotretinoin in Patients with Acne Vulgaris? Dermatol Res Pract. 2018;2018. doi:10.1155/2018/6974045
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bartosz Przemysław Herc, Małgorzata Tesla, Anna Agnieszka Gąska, Marta Gutkowska, Joanna Jabłońska, Joanna Wasik, Marta Armuła, Claire Bongage, Arkadiusz Piechowiak, Filip Napieraj

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 26
Number of citations: 0